Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-10

Clinical Trial Update: Alitretinoin in the Treatment of Chronic Hand Eczema [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of alitretinoin for chronic hand eczema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alitretinoin (alitretinoin)

Snippet

Sponsor: Basilea Pharmaceutica | Conditions: Eczema | Phase 3 | Status: COMPLETED